Attention-deficit Hyperactivity Disorder Clinical Trial
Official title:
Efficacy of Online Mindfulness-Based Intervention on Emerging Malaysian Chinese Adults With Attention Deficit/Hyperactivity Disorder: A Randomized Controlled Trial
This study aims to evaluate the efficacies of an online mindfulness-based intervention for emerging adults with ADHD in Malaysia. The investigators hypothesized that online mindfulness-based intervention may improve ADHD symptoms and executive functions of emerging adults with ADHD.
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder that often persist to adulthood. In Malaysia, the Chinese ethnic is having the highest prevalence rate of hyperactivity symptoms. Nevertheless, there are only limited evidence-based treatment options targeting the core symptoms of ADHD, as well as executive functions in adulthood. In addition, conventional psychotherapeutic approaches for adults with ADHD have found to be highly labor-intensive. Emerging adulthood is a distinct developmental stage of 18 - 29 years old, with unique challenges that rarely addressed in mental health system. Recently, mindfulness-based intervention appears to be a promising treatment for adults living with ADHD but it has not been evaluated among Malaysian emerging adults with ADHD. The investigators proposed a two-arm randomized controlled trial, comparing an eight-week online mindfulness-based intervention program with an online introductory psychology program. The outcomes include changes of inattention symptom, changes of hyperactivity-impulsivity symptom, and changes of executive functions from pretest to posttest, 1-month follow-up and 3-month follow-up. To investigators' best knowledge, this randomized controlled trial will be the first to test the efficacious of online mindfulness-based intervention for ADHD among emerging adults. It will provide evidence on the efficacious of online treatment for this often-overlooked population in the mental healthcare system. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02827188 -
Cognitive Restructuring in ADHD: Functional Training
|
N/A | |
Recruiting |
NCT05374187 -
Efficacy of Trigeminal Nerve Stimulation for ADHD
|
N/A | |
Completed |
NCT00339729 -
Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT04416360 -
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak
|
N/A | |
Recruiting |
NCT01657721 -
Working Memory Training in ADHD (The Engage Study)
|
Phase 1 | |
Completed |
NCT04786730 -
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT01323192 -
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
|
Phase 3 | |
Recruiting |
NCT05165511 -
Families, Responsibility, Education, Support, and Health for Executive Function
|
N/A | |
Completed |
NCT01886469 -
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1/Phase 2 | |
Completed |
NCT01010750 -
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1 | |
Recruiting |
NCT04729439 -
Technology-Enhanced Executive Functioning Intervention for ADHD
|
Phase 1 | |
Completed |
NCT01624649 -
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
|
Phase 4 | |
Completed |
NCT03806946 -
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
|
||
Recruiting |
NCT05869253 -
The Efficacy of Equine Assisted Occupational Therapy, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
|
N/A | |
Completed |
NCT01907360 -
Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
|
Phase 1/Phase 2 |